Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis

NCT02520284 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL: Andecaliximab
BIOLOGICAL: Placebo

Sponsor

Gilead Sciences